Ovid Therapeutics Inc.OVIDNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-157.97%
↓ 2329% below average
Average (39q)
7.09%
Historical baseline
Range
High:828.57%
Low:-266.67%
Volatility
15452.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -157.97% |
| Q2 2025 | 52.93% |
| Q1 2025 | -7.69% |
| Q4 2024 | 35.00% |
| Q3 2024 | -266.67% |
| Q2 2024 | 170.59% |
| Q1 2024 | 22.73% |
| Q4 2023 | -37.50% |
| Q3 2023 | 11.11% |
| Q2 2023 | 5.26% |
| Q1 2023 | -18.75% |
| Q4 2022 | 0.00% |
| Q3 2022 | 23.81% |
| Q2 2022 | 8.70% |
| Q1 2022 | 39.47% |
| Q4 2021 | -123.53% |
| Q3 2021 | 26.09% |
| Q2 2021 | -109.02% |
| Q1 2021 | 828.57% |
| Q4 2020 | -25.00% |
| Q3 2020 | 31.71% |
| Q2 2020 | -10.81% |
| Q1 2020 | -5.71% |
| Q4 2019 | 18.60% |
| Q3 2019 | -26.47% |
| Q2 2019 | 26.09% |
| Q1 2019 | 11.54% |
| Q4 2018 | 1.89% |
| Q3 2018 | 0.00% |
| Q2 2018 | 1.85% |
| Q1 2018 | -20.00% |
| Q4 2017 | -18.42% |
| Q3 2017 | 33.33% |
| Q2 2017 | 58.99% |
| Q1 2017 | -256.41% |
| Q4 2016 | -30.00% |
| Q3 2016 | -11.11% |
| Q2 2016 | -42.11% |
| Q1 2016 | 42.42% |
| Q4 2015 | 0.00% |